Literature DB >> 25407931

MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons.

Woori Kim1, Haneul Noh2, Yenarae Lee1, Jeha Jeon2, Arthi Shanmugavadivu1, Donna L McPhie1, Kwang-Soo Kim1, Bruce M Cohen1, Hyemyung Seo2, Kai C Sonntag3.   

Abstract

Dysfunction of growth factor (GF) activities contributes to the decline and death of neurons during aging and in neurodegenerative diseases. In addition, neurons become more resistant to GF signaling with age. Micro (mi)RNAs are posttranscriptional regulators of gene expression that may be crucial to age- and disease-related changes in GF functions. MiR-126 is involved in regulating insulin/IGF-1/phosphatidylinositol-3-kinase (PI3K)/AKT and extracellular signal-regulated kinase (ERK) signaling, and we recently demonstrated a functional role of miR-126 in dopamine neuronal cell survival in models of Parkinson's disease (PD)-associated toxicity. Here, we show that elevated levels of miR-126 increase neuronal vulnerability to ubiquitous toxicity mediated by staurosporine (STS) or Alzheimer's disease (AD)-associated amyloid beta 1-42 peptides (Aβ1-42). The neuroprotective factors IGF-1, nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and soluble amyloid precursor protein α (sAPPα) could diminish but not abrogate the toxic effects of miR-126. In miR-126 overexpressing neurons derived from Tg6799 familial AD model mice, we observed an increase in Aβ1-42 toxicity, but surprisingly, both Aβ1-42 and miR-126 promoted neurite sprouting. Pathway analysis revealed that miR-126 overexpression downregulated elements in the GF/PI3K/AKT and ERK signaling cascades, including AKT, GSK-3β, ERK, their phosphorylation, and the miR-126 targets IRS-1 and PIK3R2. Finally, inhibition of miR-126 was neuroprotective against both STS and Aβ1-42 toxicity. Our data provide evidence for a novel mechanism of regulating GF/PI3K signaling in neurons by miR-126 and suggest that miR-126 may be an important mechanistic link between metabolic dysfunction and neurotoxicity in general, during aging, and in the pathogenesis of specific neurological disorders, including PD and AD.

Entities:  

Keywords:  Aβ; Growth factors; MiR-126; Neuroprotection; Neurotoxicity; PI3K/AKT signaling

Mesh:

Substances:

Year:  2014        PMID: 25407931      PMCID: PMC4437970          DOI: 10.1007/s12035-014-8989-x

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  87 in total

1.  RNA mechanisms in CNS systems and disorders.

Authors:  Kai-Christian Sonntag; Claes Wahlestedt
Journal:  Brain Res       Date:  2010-04-07       Impact factor: 3.252

2.  Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.

Authors:  Ahmad Salehi; Jean-Dominique Delcroix; Pavel V Belichenko; Ke Zhan; Chengbiao Wu; Janice S Valletta; Ryoko Takimoto-Kimura; Alexander M Kleschevnikov; Kumar Sambamurti; Peter P Chung; Weiming Xia; Angela Villar; William A Campbell; Laura Shapiro Kulnane; Ralph A Nixon; Bruce T Lamb; Charles J Epstein; Gorazd B Stokin; Lawrence S B Goldstein; William C Mobley
Journal:  Neuron       Date:  2006-07-06       Impact factor: 17.173

Review 3.  Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.

Authors:  Elliott J Mufson; Scott E Counts; Sylvia E Perez; Stephen D Ginsberg
Journal:  Expert Rev Neurother       Date:  2008-11       Impact factor: 4.618

4.  Presenilin-1 mutations reduce cytoskeletal association, deregulate neurite growth, and potentiate neuronal dystrophy and tau phosphorylation.

Authors:  G Pigino; A Pelsman; H Mori; J Busciglio
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

5.  Dlk1 promotes a fast motor neuron biophysical signature required for peak force execution.

Authors:  Daniel Müller; Pitchaiah Cherukuri; Kristine Henningfeld; Chor Hoon Poh; Lars Wittler; Phillip Grote; Oliver Schlüter; Jennifer Schmidt; Jorge Laborda; Steven R Bauer; Robert M Brownstone; Till Marquardt
Journal:  Science       Date:  2014-03-14       Impact factor: 47.728

6.  Insulin has multiple antiamyloidogenic effects on human neuronal cells.

Authors:  Giuseppe Pandini; Vincenza Pace; Agata Copani; Sebastiano Squatrito; Danilo Milardi; Riccardo Vigneri
Journal:  Endocrinology       Date:  2012-12-13       Impact factor: 4.736

Review 7.  Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1.

Authors:  Ferenc Deak; William E Sonntag
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-04-12       Impact factor: 6.053

Review 8.  MicroRNAs (miRNAs) in neurodegenerative diseases.

Authors:  Peter T Nelson; Wang-Xia Wang; Bernard W Rajeev
Journal:  Brain Pathol       Date:  2008-01       Impact factor: 6.508

9.  Overexpression of miR-126 promotes the differentiation of mesenchymal stem cells toward endothelial cells via activation of PI3K/Akt and MAPK/ERK pathways and release of paracrine factors.

Authors:  Feng Huang; Zhen-fei Fang; Xin-qun Hu; Liang Tang; Sheng-hua Zhou; Jian-ping Huang
Journal:  Biol Chem       Date:  2013-09       Impact factor: 3.915

Review 10.  RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis.

Authors:  Sabrina M Heman-Ackah; Martina Hallegger; Mahendra S Rao; Matthew J A Wood
Journal:  Front Mol Neurosci       Date:  2013-11-20       Impact factor: 5.639

View more
  16 in total

1.  Midbrain dopamine neurons in Parkinson's disease exhibit a dysregulated miRNA and target-gene network.

Authors:  Christine E Briggs; Yulei Wang; Benjamin Kong; Tsung-Ung W Woo; Lakshmanan K Iyer; Kai C Sonntag
Journal:  Brain Res       Date:  2015-06-03       Impact factor: 3.252

Review 2.  MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases.

Authors:  T P Nhung Nguyen; Mandeep Kumar; Ernesto Fedele; Giambattista Bonanno; Tiziana Bonifacino
Journal:  Int J Mol Sci       Date:  2022-04-25       Impact factor: 6.208

Review 3.  A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease.

Authors:  P Hemachandra Reddy; Sahil Tonk; Subodh Kumar; Murali Vijayan; Ramesh Kandimalla; Chandra Sekhar Kuruva; Arubala P Reddy
Journal:  Biochem Biophys Res Commun       Date:  2016-08-12       Impact factor: 3.575

4.  Late-onset Alzheimer's disease is associated with inherent changes in bioenergetics profiles.

Authors:  Kai-C Sonntag; Woo-In Ryu; Kristopher M Amirault; Ryan A Healy; Arthur J Siegel; Donna L McPhie; Brent Forester; Bruce M Cohen
Journal:  Sci Rep       Date:  2017-10-25       Impact factor: 4.379

5.  TOM1 Regulates Neuronal Accumulation of Amyloid-β Oligomers by FcγRIIb2 Variant in Alzheimer's Disease.

Authors:  Youngdae Gwon; Tae-In Kam; Seo-Hyun Kim; Sungmin Song; Hyejin Park; Bitna Lim; Haneul Lee; Weontae Lee; Dong-Gyu Jo; Yong-Keun Jung
Journal:  J Neurosci       Date:  2018-09-05       Impact factor: 6.167

6.  A workflow for the integrative transcriptomic description of molecular pathology and the suggestion of normalizing compounds, exemplified by Parkinson's disease.

Authors:  Mohamed Hamed; Yvonne Gladbach; Steffen Möller; Sarah Fischer; Mathias Ernst; Stephan Struckmann; Alexander Storch; Georg Fuellen
Journal:  Sci Rep       Date:  2018-05-21       Impact factor: 4.379

7.  miR-129 controls axonal regeneration via regulating insulin-like growth factor-1 in peripheral nerve injury.

Authors:  Hui Zhu; Chengbin Xue; Min Yao; Hongkui Wang; Ping Zhang; Tianmei Qian; Songlin Zhou; Shiying Li; Bin Yu; Yongjun Wang; Xiaosong Gu
Journal:  Cell Death Dis       Date:  2018-06-18       Impact factor: 8.469

Review 8.  Mitochondrial Dysfunction and Mitophagy Closely Cooperate in Neurological Deficits Associated with Alzheimer's Disease and Type 2 Diabetes.

Authors:  Sangita Paul; Debarpita Saha; Binukumar Bk
Journal:  Mol Neurobiol       Date:  2021-04-01       Impact factor: 5.590

Review 9.  Mitochondrial MicroRNAs in Aging and Neurodegenerative Diseases.

Authors:  Albin John; Aaron Kubosumi; P Hemachandra Reddy
Journal:  Cells       Date:  2020-05-28       Impact factor: 6.600

Review 10.  Modulation of MicroRNAs as a Potential Molecular Mechanism Involved in the Beneficial Actions of Physical Exercise in Alzheimer Disease.

Authors:  Alex Cleber Improta-Caria; Carolina Kymie Vasques Nonaka; Bruno Raphael Ribeiro Cavalcante; Ricardo Augusto Leoni De Sousa; Roque Aras Júnior; Bruno Solano de Freitas Souza
Journal:  Int J Mol Sci       Date:  2020-07-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.